TSS:Rfhg 16907.1

Basic information about the TSS

---

TSS ID: rfhg_16907.1 TSS ID(Version3): hg_16236.1 hg_16238.1 hg_16237.1 Species: human Chr: chr1		Start: 183635572 End: 183635808 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA615891|DRA013844|PRJNA401781 |PRJNA548673|PRJNA4843412|PRJNA597322
Protocol	CAGE|C1CAGE|TIF-seq2|RAMPAGE|ReCappable-seq|NETCAGE |STRIPE-seq|SLIC_CAGE|oligo_capping
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000359856.11:0 ENST00000367534.5:0 ENST00000294742.6:0 AF006088:0 AK129598:0 BC057237:0 AF017807:0 HQ447728:0 BC152789:0 AB528796:0 CU691198:0 GeneID: 10092 HGNC/MGI_ID: HGNC:708 UniProt_ID: B1ALC0 O15511 Nearer transcript ids and distances: LF319958:13 MA555535:13 LF329024:15 MA564601:15 BC071857:-54 LF205392:-64 MA440969:-64 LF319959:218 MA555536:218 view more...

Gene_name: actin related protein 2/3 complex subunit 5 Gene_symbol: ARPC5 Gene_synonyms: ARC16 dJ127C7.3 p16-Arc Gene_source: HGNC:708

TATA-Box annotation

---

Distance to TSS:	93
Nearest PromoterID:	NM_001270439
Entrez ID:	10092
Nearest Unigene:	Hs.518609
Nearest Refseq:	NM_005717
Nearest Ensembl:	ENSG00000162704
Gene Name:	actin related protein 2/3 complex subunit 5
Gene Alias:	ARC16|dJ127C7.3|p16-Arc
Gene Type:	protein-coding
CpG%:	0.093220
GC%:	0.616034
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARPC5 p2@ARPC5
Sample		p1@ARPC5	p2@ARPC5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.40	7.01
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	40.26	7.69
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.46	7.72
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.35	5.82
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	36.44	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.53	5.43
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	53.38	7.84
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	43.12	5.81
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.42	7.69
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	5.80
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.36	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.89	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	111.06	14.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	93.22	15.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	87.16	20.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	73.69	9.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	76.01	12.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	82.25	15.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	75.17	16.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	98.99	16.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	99.04	18.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	101.33	15.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	83.50	15.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	77.65	13.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	90.55	14.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	87.67	16.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	88.46	15.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	104.67	16.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	85.45	13.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	91.21	18.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	77.46	13.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	84.99	13.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	89.69	15.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	127.66	21.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	96.86	16.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	83.16	15.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	115.68	18.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	89.66	13.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	99.94	15.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	109.95	17.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	97.40	14.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	133.22	20.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	122.32	17.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	129.20	18.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	131.51	15.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	135.40	19.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	117.55	15.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	155.58	22.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	141.47	10.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	157.11	17.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	151.87	19.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	153.88	17.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1301.27	237.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	90.13	10.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	82.18	9.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	513.43	64.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	271.41	31.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	86.86	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	76.44	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	329.42	31.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	74.03	13.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	93.65	10.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	771.46	54.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	375.78	26.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	115.02	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	117.85	6.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2004.33	129.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2298.17	292.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	118.95	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	166.12	11.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	155.75	9.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	315.29	18.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	91.26	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	107.62	6.73
Adipocyte - breast, donor1	11376-118A8	284.77	12.99
Adipocyte - breast, donor2	11327-117E4	145.19	15.56
Adipocyte - omental, donor1	11473-119C6	295.17	15.90
Adipocyte - omental, donor2	11474-119C7	208.55	14.95
Adipocyte - omental, donor3	11475-119C8	116.22	14.40
Adipocyte - perirenal, donor1	11476-119C9	192.04	22.33
Adipocyte - subcutaneous, donor1	11259-116F8	56.07	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	133.68	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	34.58	4.00
Adipocyte differentiation, day04, donor1	13019-139D4	109.52	7.63
Adipocyte differentiation, day04, donor2	13022-139D7	112.47	5.40
Adipocyte differentiation, day04, donor3	13025-139E1	128.24	5.58
Adipocyte differentiation, day04, donor4	13028-139E4	103.45	9.40
Adipocyte differentiation, day08, donor1	13020-139D5	81.40	12.06
Adipocyte differentiation, day08, donor2	13023-139D8	121.68	6.46
Adipocyte differentiation, day08, donor3	13026-139E2	81.58	11.73
Adipocyte differentiation, day08, donor4	13029-139E5	83.47	13.91
Adipocyte differentiation, day12, donor1	13021-139D6	47.41	13.31
Adipocyte differentiation, day12, donor2	13024-139D9	108.75	7.28
Adipocyte differentiation, day12, donor3	13027-139E3	74.61	7.85
Adipocyte differentiation, day12, donor4	13030-139E6	59.07	7.61
Alveolar Epithelial Cells, donor1	11510-119G7	124.64	10.17
Alveolar Epithelial Cells, donor2	11590-120G6	22.59	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	85.46	6.12
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	76.63	5.14
Anulus Pulposus Cell, donor1	11248-116E6	99.09	14.19
Anulus Pulposus Cell, donor2	11463-119B5	76.90	9.06
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	150.96	11.68
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	162.37	10.42
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	121.99	10.70
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	169.19	5.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	159.35	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	126.07	4.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	144.57	8.45
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	176.70	8.74
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	136.00	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	151.41	8.66
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	137.15	9.43
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	141.68	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	236.40	8.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	152.86	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	155.47	5.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	167.17	7.50
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	185.91	9.82
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	188.44	6.15
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	125.83	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	171.50	8.46
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	130.88	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	173.47	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	176.68	6.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	121.65	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	163.59	7.77
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	179.10	12.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	147.79	8.48
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	149.92	5.70
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	172.09	8.34
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	136.27	6.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	132.32	7.98
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	169.14	6.43
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	149.82	6.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	150.33	5.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	183.05	4.82
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	158.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	147.48	8.65
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	175.99	7.39
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	126.44	8.26
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	146.29	5.61
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	175.06	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	135.71	7.25
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	142.66	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	171.73	7.63
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	152.88	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	141.54	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	172.39	7.08
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	149.21	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	141.42	9.48
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	186.20	6.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	117.31	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	182.79	6.36
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	195.70	7.64
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	133.72	5.81
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	169.69	6.69
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	178.06	5.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	112.91	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	140.69	6.09
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	177.68	9.27
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	128.30	3.27
Astrocyte - cerebellum, donor1	11500-119F6	136.45	14.37
Astrocyte - cerebellum, donor2	11580-120F5	70.00	6.50
Astrocyte - cerebellum, donor3	11661-122F5	43.21	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	148.15	34.86
Astrocyte - cerebral cortex, donor2	11316-117D2	125.21	20.87
Astrocyte - cerebral cortex, donor3	11392-118C6	157.66	25.36
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	409.77	12.96
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	434.98	13.28
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	413.54	12.86
Basophils, donor1	12241-129G9	291.61	5.23
Basophils, donor2	12242-129H1	275.65	9.74
Basophils, donor3	12243-129H2	131.56	6.32
Bronchial Epithelial Cell, donor1	11511-119G8	59.29	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	19.66	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	111.72	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	66.75	4.99
Bronchial Epithelial Cell, donor6	11461-119B3	95.11	5.07
Bronchial Epithelial Cell, donor7	11769-123I5	88.17	8.82
Burkitt's lymphoma cell line:DAUDI	10422-106C8	185.19	4.02
Burkitt's lymphoma cell line:RAJI	10476-106I8	185.86	10.71
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	186.11	6.40
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	20.68
CD14+ Monocytes, donor1	11224-116B9	184.85	7.89
CD14+ Monocytes, donor2	11305-117B9	110.99	6.87
CD14+ Monocytes, donor3	11381-118B4	112.40	8.34
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	863.28	15.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	765.35	17.82
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	881.68	15.12
CD14+ monocytes - mock treated, donor1	11863-125A9	387.10	10.70
CD14+ monocytes - mock treated, donor2	11873-125C1	286.66	10.26
CD14+ monocytes - mock treated, donor3	11883-125D2	388.98	7.58
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	333.12	11.89
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	248.41	5.80
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	380.82	7.93
CD14+ monocytes - treated with BCG, donor1	11860-125A6	341.08	10.77
CD14+ monocytes - treated with BCG, donor2	11870-125B7	273.13	11.22
CD14+ monocytes - treated with BCG, donor3	11880-125C8	559.31	9.58
CD14+ monocytes - treated with Candida, donor1	11868-125B5	240.45	12.88
CD14+ monocytes - treated with Candida, donor2	11878-125C6	218.60	8.45
CD14+ monocytes - treated with Candida, donor3	11888-125D7	252.93	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	320.70	9.82
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	263.00	8.78
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	544.86	10.20
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	327.16	12.13
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	300.40	9.27
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	253.58	6.11
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	399.45	15.33
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	345.26	9.25
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	473.42	11.36
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	469.01	15.43
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	407.57	14.80
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	562.45	9.21
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	336.37	13.78
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	266.86	8.55
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	506.54	10.35
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	420.95	17.20
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	341.90	15.76
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	529.17	9.05
CD14+CD16+ Monocytes, donor1	11789-124B7	615.31	13.95
CD14+CD16+ Monocytes, donor2	11801-124D1	499.41	9.24
CD14+CD16+ Monocytes, donor3	11912-125G4	581.18	14.95
CD14+CD16- Monocytes, donor1	11788-124B6	600.46	11.52
CD14+CD16- Monocytes, donor2	11799-124C8	431.37	8.91
CD14+CD16- Monocytes, donor3	11910-125G2	721.31	15.16
CD14-CD16+ Monocytes, donor1	11790-124B8	613.70	14.29
CD14-CD16+ Monocytes, donor2	11800-124C9	523.66	16.47
CD14-CD16+ Monocytes, donor3	11911-125G3	709.96	18.53
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	298.75	22.36
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	297.63	18.98
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	324.14	27.96
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	342.74	12.79
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	358.09	17.15
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	277.97	24.57
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	285.51	22.75
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	325.62	25.05
CD19+ B Cells, donor1	11544-120B5	59.18	13.97
CD19+ B Cells, donor2	11624-122B4	66.74	8.71
CD19+ B Cells, donor3	11705-123B4	42.91	7.57
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	107.48	28.69
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	76.70	28.36
CD34+ Progenitors, donor1	11545-120B6	80.32	2.01
CD34+ Progenitors, donor2	11625-122B5	79.78	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	222.82	7.14
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	229.54	7.89
CD4+ T Cells, donor1	11225-116C1	77.84	9.28
CD4+ T Cells, donor2	11306-117C1	62.46	9.19
CD4+ T Cells, donor3	11382-118B5	133.59	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	304.50	15.31
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	223.70	12.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	250.95	12.36
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	167.83	11.85
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	172.07	10.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	145.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	321.84	12.57
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	212.85	8.47
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	216.02	8.22
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	229.53	8.97
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	205.09	12.23
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	290.83	14.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	387.91	15.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	253.27	8.73
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	261.96	9.02
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	255.89	13.05
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	217.60	13.40
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	272.57	14.35
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	512.34	18.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	284.42	11.26
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	349.69	13.24
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	251.79	11.12
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	226.16	9.96
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	329.48	17.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	443.40	38.10
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	321.27	24.93
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	369.89	30.71
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	507.61	26.31
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	599.24	25.77
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	443.52	36.96
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	422.94	36.53
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	468.13	37.39
CD8+ T Cells, donor1	11226-116C2	99.53	7.86
CD8+ T Cells, donor2	11307-117C2	58.19	7.13
CD8+ T Cells, donor3	11383-118B6	73.98	9.34
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	77.53	6.19
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	83.87	7.91
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	73.32	4.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	89.76	7.21
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	72.95	6.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	82.31	8.19
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	82.35	6.08
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	77.38	5.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	98.97	8.44
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	94.49	8.45
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.12	6.68
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	87.12	6.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	80.11	9.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	89.72	7.74
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	73.84	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	77.43	5.04
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	100.13	5.18
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	82.97	5.66
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	88.42	8.56
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	90.12	3.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	92.01	8.66
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	75.73	6.12
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	61.09	8.67
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	59.00	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.00	12.04
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.94	9.79
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	77.13	15.03
Cardiac Myocyte, donor1	11525-119I4	275.99	32.90
Cardiac Myocyte, donor2	11605-120I3	102.28	11.36
Cardiac Myocyte, donor3	11686-122I3	227.83	12.31
Chondrocyte - de diff, donor1	11261-116G1	208.35	10.05
Chondrocyte - de diff, donor2	11338-117F6	207.90	14.57
Chondrocyte - de diff, donor3	11410-118E6	148.94	18.77
Chondrocyte - re diff, donor2	11339-117F7	377.80	19.70
Chondrocyte - re diff, donor3	11411-118E7	128.60	4.85
Ciliary Epithelial Cells, donor1	11242-116D9	198.88	36.03
Ciliary Epithelial Cells, donor2	11323-117D9	198.37	17.53
Ciliary Epithelial Cells, donor3	11399-118D4	155.05	14.69
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	98.85	19.99
Corneal Epithelial Cells, donor1	11526-119I5	30.30	2.63
Corneal Epithelial Cells, donor2	11606-120I4	47.78	3.41
Corneal Epithelial Cells, donor3	11687-122I4	39.11	4.60
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	611.02	6.93
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	629.24	5.99
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	741.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	481.42	4.21
Dendritic Cells - plasmacytoid, donor1	11228-116C4	242.91	6.49
Dendritic Cells - plasmacytoid, donor2	11309-117C4	462.88	12.40
Dendritic Cells - plasmacytoid, donor3	11385-118B8	370.22	9.68
Endothelial Cells - Aortic, donor0	11207-116A1	259.83	4.17
Endothelial Cells - Aortic, donor1	11263-116G3	200.09	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	254.80	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	283.49	4.72
Endothelial Cells - Artery, donor1	11264-116G4	132.93	2.04
Endothelial Cells - Artery, donor2	11341-117F9	100.46	1.88
Endothelial Cells - Artery, donor3	11413-118E9	162.16	2.28
Endothelial Cells - Lymphatic, donor1	11236-116D3	182.42	5.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	215.12	4.56
Endothelial Cells - Lymphatic, donor3	11393-118C7	214.25	3.66
Endothelial Cells - Microvascular, donor1	11265-116G5	183.63	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	181.71	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	127.61	2.55
Endothelial Cells - Thoracic, donor1	11266-116G6	230.87	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	135.22	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	287.38	4.35
Endothelial Cells - Umbilical vein, donor2	11324-117E1	174.68	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	188.69	2.81
Endothelial Cells - Vein, donor1	11267-116G7	122.85	3.41
Endothelial Cells - Vein, donor2	11344-117G3	206.76	2.10
Endothelial Cells - Vein, donor3	11416-118F3	194.53	2.51
Eosinophils, donor1	12244-129H3	548.89	15.25
Eosinophils, donor2	12245-129H4	998.41	31.35
Eosinophils, donor3	12246-129H5	1337.56	28.53
Esophageal Epithelial Cells, donor1	11507-119G4	41.05	4.64
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	265.60	6.57
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	119.12	10.07
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	221.88	8.56
Fibroblast - Aortic Adventitial, donor1	11245-116E3	269.24	16.98
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	156.12	19.24
Fibroblast - Aortic Adventitial, donor2	11326-117E3	179.61	18.46
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	98.55	5.80
Fibroblast - Aortic Adventitial, donor3	11401-118D6	212.94	11.29
Fibroblast - Cardiac, donor1	11268-116G8	199.14	10.89
Fibroblast - Cardiac, donor2	11345-117G4	169.78	6.06
Fibroblast - Cardiac, donor3	11417-118F4	103.46	5.05
Fibroblast - Cardiac, donor4	11452-119A3	174.59	14.25
Fibroblast - Cardiac, donor5	11456-119A7	227.29	3.93
Fibroblast - Cardiac, donor6	11460-119B2	170.54	4.85
Fibroblast - Choroid Plexus, donor1	11492-119E7	155.96	10.99
Fibroblast - Choroid Plexus, donor2	11572-120E6	110.88	8.20
Fibroblast - Choroid Plexus, donor3	11653-122E6	162.59	23.44
Fibroblast - Conjunctival, donor1	11531-120A1	50.51	3.69
Fibroblast - Conjunctival, donor3	11692-122I9	81.24	14.08
Fibroblast - Dermal, donor1	11269-116G9	114.34	11.03
Fibroblast - Dermal, donor2	11346-117G5	223.10	0.94
Fibroblast - Dermal, donor3	11418-118F5	190.52	5.20
Fibroblast - Dermal, donor4	11450-119A1	115.65	8.03
Fibroblast - Dermal, donor5	11454-119A5	103.97	13.96
Fibroblast - Dermal, donor6	11458-119A9	126.20	16.89
Fibroblast - Gingival, donor1	11237-116D4	137.64	18.12
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	235.01	27.25
Fibroblast - Gingival, donor2	11318-117D4	170.00	10.81
Fibroblast - Gingival, donor3	11394-118C8	78.03	13.15
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	156.87	28.05
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	138.67	18.68
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	238.52	18.24
Fibroblast - Gingival, donor6 (control)	11922-125H5	211.23	12.31
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	116.45	10.23
Fibroblast - Gingival, donor7 (control)	11924-125H7	271.43	28.37
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	252.80	27.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	302.75	28.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	152.90	22.30
Fibroblast - Lung, donor1	11270-116H1	51.66	5.44
Fibroblast - Lung, donor2	11347-117G6	159.66	11.94
Fibroblast - Lung, donor3	11419-118F6	127.89	6.75
Fibroblast - Lymphatic, donor1	11506-119G3	150.78	5.00
Fibroblast - Lymphatic, donor2	11586-120G2	116.09	11.19
Fibroblast - Lymphatic, donor3	11667-122G2	41.42	1.12
Fibroblast - Mammary, donor1	11540-120B1	149.80	2.84
Fibroblast - Mammary, donor2	11620-122A9	51.92	0.00
Fibroblast - Mammary, donor3	11701-123A9	125.08	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	158.09	17.85
Fibroblast - Periodontal Ligament, donor2	11319-117D5	158.36	10.77
Fibroblast - Periodontal Ligament, donor3	11395-118C9	197.06	18.36
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	193.48	17.17
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	255.14	26.73
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	176.05	17.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	245.60	14.70
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	153.00	7.52
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	56.13	6.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	103.98	9.09
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	142.09	8.14
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	211.01	15.10
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	260.94	14.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	104.10	9.33
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	240.08	21.81
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	172.85	12.15
Fibroblast - skin normal, donor1	11553-120C5	250.22	19.20
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	160.00	11.43
Fibroblast - skin normal, donor2	11561-120D4	370.40	14.67
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	177.41	6.35
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	245.06	9.20
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	217.96	5.47
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	138.60	12.15
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	400.73	19.81
Fibroblast - skin walker warburg, donor1	11554-120C6	297.89	8.27
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	422.16	23.21
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2947.25	132.96
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	110.68	25.27
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	219.99	17.86
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	201.95	13.79
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	201.34	12.52
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	14.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	32.54	13.40
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	50.78	11.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.29	17.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.93	12.33
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	39.82	8.92
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.18	13.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	50.55	9.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	27.42	10.17
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.29	5.79
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	60.96	8.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.43	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	101.10	12.02
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	93.71	8.44
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	81.32	6.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	100.17	5.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	90.31	8.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	83.28	6.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.69	4.73
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	89.65	10.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.70	6.93
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	81.26	5.44
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	102.46	10.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	130.88	6.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.92	6.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	97.68	7.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	84.76	9.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	113.90	6.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.50	6.94
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	82.52	8.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	79.90	7.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	89.05	7.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	70.98	4.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	92.61	9.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	80.72	4.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.27	3.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	91.15	6.82
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	76.08	5.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	100.65	6.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	102.76	9.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	73.99	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	95.95	7.01
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	130.55	8.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	110.97	5.35
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	134.03	4.44
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	126.56	7.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	101.65	6.78
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	118.35	6.45
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	107.02	6.14
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	103.14	4.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	144.44	7.12
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	118.63	6.25
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.54	7.88
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	56.73	5.97
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.66	4.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	37.85	9.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	54.45	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.67	7.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.36	6.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	78.91	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	105.89	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	60.86	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	66.30	4.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	60.12	5.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	61.12	5.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	71.25	6.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.57	6.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	68.15	8.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	46.17	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	76.24	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	101.48	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.49	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	57.28	7.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	66.17	8.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.18	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	67.81	9.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	99.28	6.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	45.30	8.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	68.19	7.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	67.15	5.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	69.80	7.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	70.06	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	54.30	10.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	57.18	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.05	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	53.40	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	69.24	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	67.45	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	198.59	10.27
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	93.56	9.15
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	167.54	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	197.27	13.96
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	111.54	12.11
Hep-2 cells mock treated, biol_rep1	11898-125E8	225.59	34.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	250.33	38.99
Hep-2 cells mock treated, biol_rep3	11900-125F1	222.50	37.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	226.38	35.42
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	220.93	37.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	208.18	39.83
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	209.47	32.38
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	196.42	33.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	179.09	30.76
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	108.01	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	55.83	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	161.27	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	126.98	13.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	89.36	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	128.51	10.67
Hepatocyte, donor1	11523-119I2	50.85	9.68
Hepatocyte, donor2	11603-120I1	65.72	11.85
Hepatocyte, donor3	11684-122I1	78.53	5.52
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	201.68	19.58
Intestinal epithelial cells (polarized), donor1	11246-116E4	87.39	26.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	156.42	18.93
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	31.84	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	56.85	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	28.82	6.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	36.53	6.93
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.72	9.04
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	26.89	11.41
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.15	5.04
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	27.33	6.43
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	7.39
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	34.46	8.97
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	10.76
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	11.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	7.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	9.95
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	33.64	8.33
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	5.23
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	4.23
Keratinocyte - epidermal, donor1	11272-116H3	78.82	5.39
Keratinocyte - epidermal, donor2	11349-117G8	50.95	4.10
Keratinocyte - epidermal, donor3	11421-118F8	137.06	14.01
Keratinocyte - oral, donor1	11251-116E9	91.04	12.71
Keratocytes, donor1	11527-119I6	80.11	8.60
Keratocytes, donor2	11607-120I5	41.01	10.55
Keratocytes, donor3	11688-122I5	78.64	11.26
Krukenberg tumor cell line:HSKTC	10687-109F3	215.40	70.33
Lens Epithelial Cells, donor1	11529-119I8	153.18	14.02
Lens Epithelial Cells, donor2	11609-120I7	102.88	27.79
Lens Epithelial Cells, donor3	11690-122I7	333.00	10.09
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	171.11	4.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	123.35	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	151.59	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	112.92	4.84
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	123.86	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	116.87	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	128.04	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	114.78	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	107.96	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	123.41	4.35
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	141.15	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	82.39	2.41
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	138.67	4.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	122.84	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	114.27	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	137.66	4.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	88.54	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	114.00	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	113.54	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	97.53	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	94.84	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	113.97	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	139.76	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	122.62	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	121.83	4.67
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	136.73	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	119.40	3.16
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	108.00	6.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	127.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	107.73	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	117.27	5.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	125.70	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	96.26	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	150.68	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	130.95	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	101.33	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	126.40	4.18
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	142.12	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	145.70	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	134.05	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	110.53	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	82.01	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	116.38	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	131.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	74.39	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	166.69	3.09
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	89.39	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	106.51	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	88.37	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	70.58	16.88
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	72.74	11.13
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	56.28	12.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	46.42	8.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	49.50	7.47
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	51.01	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	47.58	11.89
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	71.02	12.67
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	73.00	13.09
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.48	11.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	75.06	13.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	55.97	10.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	77.98	12.70
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	19.32
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	11.72
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	78.97	15.21
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	81.25	16.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	66.88	7.36
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	72.57	16.31
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	74.34	14.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	79.03	14.01
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	71.09	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	83.90	17.13
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	75.33	15.25
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	75.80	13.28
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	67.87	13.08
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	67.49	9.59
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	66.77	14.97
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	66.77	16.89
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	82.09	9.62
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.84	10.67
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	59.20	8.13
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	75.41	9.34
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	79.92	17.93
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	77.29	11.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	85.72	10.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	65.93	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	71.63	13.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	64.55	10.86
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	68.97	14.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	59.46	11.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	72.46	11.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	69.36	10.10
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	71.49	14.45
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	137.23	12.79
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	74.04	8.46
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.42	12.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	69.78	13.08
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	53.66	9.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	61.66	14.80
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	58.34	5.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.90	15.59
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	72.55	9.01
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	12.05
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	68.14	18.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	61.78	11.73
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	70.59	9.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	70.57	17.12
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	84.01	13.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	74.92	14.54
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	73.75	12.81
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	72.51	16.20
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	74.94	17.22
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	74.98	14.42
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	75.53	13.91
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	66.23	13.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.19	8.30
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	72.96	13.68
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.27	11.36
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	59.26	8.47
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	70.67	9.51
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	67.70	10.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	49.42	10.34
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	70.96	13.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	69.32	12.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.83	10.78
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	74.05	10.40
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	10.96
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	58.46	8.77
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	69.23	11.15
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	70.92	12.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.20	11.76
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.76	14.95
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	92.69	12.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	81.80	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	67.81	18.24
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	66.72	9.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	67.30	10.94
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	77.06	12.92
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	112.82	13.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	73.60	13.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	4.16
Macrophage - monocyte derived, donor1	11232-116C8	624.03	10.71
Macrophage - monocyte derived, donor2	11313-117C8	587.41	5.69
Macrophage - monocyte derived, donor3	11389-118C3	501.91	7.60
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	270.29	19.12
Mallassez-derived cells, donor2	11929-125I3	293.45	25.51
Mallassez-derived cells, donor3	11930-125I4	268.66	26.69
Mammary Epithelial Cell, donor1	11273-116H4	188.53	4.58
Mammary Epithelial Cell, donor2	11350-117G9	165.91	4.05
Mammary Epithelial Cell, donor3	11422-118F9	101.02	5.24
Mast cell - stimulated, donor1	11487-119E2	372.19	9.49
Mast cell, donor1	11563-120D6	234.77	8.54
Mast cell, donor2	11565-120D8	173.55	15.16
Mast cell, donor3	11566-120D9	170.87	14.18
Mast cell, donor4	11567-120E1	152.11	11.17
Mast cell, expanded and stimulated, donor5	11940-126A5	302.74	11.53
Mast cell, expanded and stimulated, donor8	11942-126A7	227.05	1.75
Mast cell, expanded, donor5	11939-126A4	240.69	9.87
Mast cell, expanded, donor8	11941-126A6	183.77	5.52
Melanocyte - dark, donor1	11502-119F8	179.00	3.08
Melanocyte - dark, donor2	11582-120F7	118.36	8.65
Melanocyte - dark, donor3	11663-122F7	188.35	6.37
Melanocyte - light, donor1	11274-116H5	75.46	2.35
Melanocyte - light, donor2	11351-117H1	70.29	4.78
Melanocyte - light, donor3	11423-118G1	40.76	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	104.33	4.89
Melanocyte, donor2 (MC+2)	12739-135I3	103.81	7.80
Melanocyte, donor3 (MC+3)	12837-137B2	82.77	10.71
Meningeal Cells, donor1	11493-119E8	207.55	8.81
Meningeal Cells, donor2	11573-120E7	188.38	4.84
Meningeal Cells, donor3	11654-122E7	252.25	8.23
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	216.15	9.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	166.65	12.48
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	24.97	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	188.73	11.48
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	202.45	16.52
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	206.08	15.58
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	109.44	9.23
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	94.25	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	77.34	6.55
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	221.89	13.44
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	58.36	3.72
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	182.49	12.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.19	2.97
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	106.95	12.81
Mesenchymal stem cells - adipose, donor0	11217-116B2	284.97	11.34
Mesenchymal stem cells - hepatic, donor0	11218-116B3	187.32	11.26
Mesenchymal stem cells - umbilical, donor0	11214-116A8	152.40	13.79
Mesothelial Cells, donor1	11247-116E5	225.40	16.44
Mesothelial Cells, donor2	12156-128G5	199.69	10.51
Mesothelial Cells, donor3	11402-118D7	246.57	5.13
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	518.52	10.80
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	571.60	11.57
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	546.22	3.53
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	497.82	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	468.95	8.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	417.36	4.15
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	347.41	9.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	413.43	9.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	592.09	5.59
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	486.65	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	396.47	8.94
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	478.72	2.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	316.40	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	262.83	9.73
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	452.13	5.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	477.67	15.79
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	345.08	4.88
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	352.68	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	304.02	7.15
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	352.10	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	371.59	6.77
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	424.00	4.52
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	534.64	17.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	343.53	6.45
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	437.08	3.16
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	310.02	11.62
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	354.63	6.87
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	439.25	4.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	309.55	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	325.24	6.57
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	387.31	2.53
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	447.39	13.26
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	422.91	11.42
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	495.53	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	326.01	13.08
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	321.97	5.29
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	461.86	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	308.52	20.57
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	383.44	7.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	565.89	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	277.24	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	438.36	12.70
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	431.53	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	341.33	15.37
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	438.32	10.41
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	402.92	4.18
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	362.42	15.47
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	361.71	12.65
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	383.35	6.13
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	303.96	22.37
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	383.51	14.31
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	573.57	5.82
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	270.39	18.65
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	298.35	10.86
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	557.22	6.68
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	317.63	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	394.36	11.08
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	529.85	6.26
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	277.61	23.08
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	335.08	13.22
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	507.48	7.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	324.58	19.69
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	368.84	12.81
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	464.56	6.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	239.43	19.35
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	322.34	13.06
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	551.50	9.73
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	336.73	22.75
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	364.79	12.50
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	486.94	8.11
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	310.85	26.72
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	354.89	16.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	440.27	6.34
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	410.50	14.43
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	399.92	11.02
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	376.69	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	347.54	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	459.01	4.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	393.43	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	485.12	6.72
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	497.33	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	583.20	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	489.54	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	576.14	14.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	296.90	8.84
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	368.99	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	448.01	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	996.73	26.72
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	258.88	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	349.44	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	571.32	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1184.89	21.79
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	848.15	17.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1194.51	6.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	786.94	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	251.25	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	884.12	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	560.79	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	250.98	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	364.52	18.74
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	189.71	9.93
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	128.83	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	142.74	9.18
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1036.84	28.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	180.33	28.73
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	53.72	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1249.60	93.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	56.50	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	161.78	10.92
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	63.50	3.24
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	76.95	10.93
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1035.53	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	67.50	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	295.30	5.14
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	67.10	3.85
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	97.16	2.61
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	87.66	10.75
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	54.10	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	43.82	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	795.50	20.02
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	66.51	4.88
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	91.37	12.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	44.30	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	73.55	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	90.94	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	760.48	63.11
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1739.57	136.54
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	84.44	10.92
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	69.86	3.81
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	183.71	8.78
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	78.12	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1417.36	153.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	82.64	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	70.33	9.92
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	54.76	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	73.36	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	185.40	4.16
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	86.69	4.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.22	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	108.55	16.28
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	56.44	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	49.86	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	72.92	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	74.27	5.36
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	97.69	7.56
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	123.11	11.94
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	47.44	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	843.07	61.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	57.92	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	95.05	6.92
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.45	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	61.71	9.49
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	696.06	24.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	743.51	55.64
Myoblast, donor1	11241-116D8	237.52	20.75
Myoblast, donor2	11322-117D8	174.72	11.12
Myoblast, donor3	11398-118D3	242.66	11.44
NK T cell leukemia cell line:KHYG-1	10777-110G3	162.72	11.38
Natural Killer Cells, donor1	11230-116C6	153.14	13.84
Natural Killer Cells, donor2	11311-117C6	81.42	8.14
Natural Killer Cells, donor3	11387-118C1	85.59	8.83
Neural stem cells, donor1	11275-116H6	190.54	23.59
Neural stem cells, donor2	11352-117H2	159.83	38.51
Neurons, donor1	11494-119E9	216.20	63.72
Neurons, donor2	11574-120E8	232.05	43.59
Neurons, donor3	11655-122E8	144.70	30.42
Neutrophils, donor1	11233-116C9	1661.13	19.49
Neutrophils, donor2	11314-117C9	965.33	28.99
Neutrophils, donor3	11390-118C4	1707.92	54.36
Nucleus Pulposus Cell, donor1	11252-116F1	89.17	10.57
Nucleus Pulposus Cell, donor2	11409-118E5	67.73	7.16
Nucleus Pulposus Cell, donor3	11462-119B4	100.68	12.43
Olfactory epithelial cells, donor1	11933-125I7	143.16	11.56
Olfactory epithelial cells, donor2	11934-125I8	176.88	23.45
Olfactory epithelial cells, donor3	11935-125I9	165.83	22.36
Olfactory epithelial cells, donor4	11936-126A1	182.43	19.87
Oligodendrocyte - precursors, donor1	11496-119F2	201.61	18.05
Osteoblast - differentiated, donor1	11276-116H7	193.98	7.44
Osteoblast - differentiated, donor2	11353-117H3	78.87	6.86
Osteoblast - differentiated, donor3	11425-118G3	80.07	6.21
Osteoblast, donor1	11277-116H8	154.00	9.77
Osteoblast, donor2	11354-117H4	271.09	30.90
Osteoblast, donor3	11426-118G4	364.88	8.89
Pancreatic stromal cells, donor1	11249-116E7	219.69	7.33
Pericytes, donor1	11491-119E6	18.25	3.67
Pericytes, donor2	11571-120E5	25.81	1.58
Pericytes, donor3	11652-122E5	116.37	7.32
Perineurial Cells, donor1	11499-119F5	134.61	14.24
Perineurial Cells, donor2	11579-120F4	171.69	10.40
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	292.92	7.01
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	173.12	5.63
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	167.85	5.05
Placental Epithelial Cells, donor1	11278-116H9	29.66	4.54
Placental Epithelial Cells, donor2	11355-117H5	73.19	4.44
Placental Epithelial Cells, donor3	11427-118G5	49.08	4.91
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	183.86	17.09
Preadipocyte - breast, donor1	11467-119B9	229.79	12.01
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	147.76	14.75
Preadipocyte - breast, donor2	11328-117E5	222.22	24.09
Preadipocyte - omental, donor1	11468-119C1	301.56	23.76
Preadipocyte - omental, donor2	11329-117E6	298.55	17.02
Preadipocyte - omental, donor3	11403-118D8	310.56	31.37
Preadipocyte - perirenal, donor1	11469-119C2	181.11	27.56
Preadipocyte - subcutaneous, donor1	11279-116I1	180.89	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	338.39	5.49
Preadipocyte - subcutaneous, donor3	11428-118G6	238.57	9.20
Preadipocyte - visceral, donor1	11280-116I2	310.83	13.51
Preadipocyte - visceral, donor2	11357-117H7	256.78	10.58
Preadipocyte - visceral, donor3	11429-118G7	190.28	15.88
Prostate Epithelial Cells (polarized), donor1	11253-116F2	76.03	21.12
Prostate Epithelial Cells, donor2	11331-117E8	101.42	9.48
Prostate Epithelial Cells, donor3	11404-118D9	84.45	11.70
Prostate Stromal Cells, donor1	11254-116F3	216.75	27.45
Prostate Stromal Cells, donor2	11332-117E9	234.52	14.34
Prostate Stromal Cells, donor3	11405-118E1	133.79	11.57
Renal Cortical Epithelial Cells, donor1	11516-119H4	49.27	2.55
Renal Cortical Epithelial Cells, donor2	11596-120H3	118.25	8.39
Renal Epithelial Cells, donor1	11517-119H5	34.49	1.01
Renal Epithelial Cells, donor2	11597-120H4	33.43	1.42
Renal Epithelial Cells, donor3	11678-122H4	139.32	5.40
Renal Glomerular Endothelial Cells, donor1	11514-119H2	61.96	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	112.53	3.77
Renal Glomerular Endothelial Cells, donor3	11675-122H1	212.69	4.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	34.60	0.00
Renal Mesangial Cells, donor1	11518-119H6	65.37	8.80
Renal Mesangial Cells, donor2	11598-120H5	73.36	8.15
Renal Mesangial Cells, donor3	11679-122H5	26.91	4.16
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	104.15	6.17
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	44.28	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	57.47	7.14
Retinal Pigment Epithelial Cells, donor0	11215-116A9	77.53	24.63
Retinal Pigment Epithelial Cells, donor1	11528-119I7	116.82	20.18
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	8.23
Retinal Pigment Epithelial Cells, donor3	11689-122I6	89.57	17.31
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	148.20	21.38
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	130.44	8.93
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	225.10	4.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	187.36	5.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	223.77	9.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	139.23	7.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	220.85	14.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	285.18	13.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	158.04	9.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	204.09	11.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	150.33	4.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	160.35	10.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	231.16	14.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	155.22	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	150.13	8.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	172.81	8.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	151.79	6.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	157.72	8.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	263.45	9.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	179.55	7.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	148.06	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	198.79	12.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	167.88	8.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	155.29	7.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	198.58	11.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	171.21	4.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	142.50	7.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	183.21	11.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	176.43	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	155.95	9.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	184.74	8.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	149.30	6.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	170.55	9.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	181.10	9.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	166.75	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	166.89	8.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	177.95	11.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	175.03	6.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	168.44	8.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	200.94	9.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	159.52	6.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	200.33	12.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	183.65	7.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	125.82	7.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	193.58	10.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	213.43	14.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	181.10	8.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	173.28	10.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	152.62	8.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	216.99	8.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	202.32	8.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	152.72	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	209.77	6.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	136.62	6.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	161.75	10.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	176.40	6.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	154.53	8.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	184.50	6.01
Schwann Cells, donor1	11498-119F4	53.98	3.39
Schwann Cells, donor2	11578-120F3	91.87	13.61
Schwann Cells, donor3	11659-122F3	132.54	7.89
Sebocyte, donor1	11220-116B5	138.04	12.60
Sebocyte, donor2	11301-117B5	84.56	11.49
Sebocyte, donor3	11378-118B1	111.30	6.80
Sertoli Cells, donor1	11255-116F4	316.41	19.88
Sertoli Cells, donor2	11333-117F1	200.53	0.00
Skeletal Muscle Cells, donor1	11281-116I3	122.38	7.48
Skeletal Muscle Cells, donor2	11358-117H8	31.08	2.17
Skeletal Muscle Cells, donor3	11430-118G8	117.88	2.51
Skeletal Muscle Cells, donor4	11451-119A2	131.02	18.07
Skeletal Muscle Cells, donor5	11455-119A6	102.42	14.57
Skeletal Muscle Cells, donor6	11459-119B1	129.43	12.93
Skeletal Muscle Satellite Cells, donor1	11240-116D7	244.96	16.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	153.25	12.56
Skeletal Muscle Satellite Cells, donor3	11397-118D2	168.06	9.82
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	111.13	7.33
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	65.86	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	114.90	4.40
Skin - palm, donor1	10286-104F7	174.60	53.72
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	81.88	5.48
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	89.15	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	72.96	4.28
Small Airway Epithelial Cells, donor1	11256-116F5	182.80	6.12
Small Airway Epithelial Cells, donor2	11334-117F2	103.52	6.05
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	113.55	6.77
Small Airway Epithelial Cells, donor3	11406-118E2	90.17	8.77
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	232.36	19.44
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	91.16	11.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	204.56	18.81
Smooth Muscle Cells - Aortic, donor1	11283-116I5	172.37	4.64
Smooth Muscle Cells - Aortic, donor2	11360-117I1	225.64	4.33
Smooth Muscle Cells - Aortic, donor3	11432-118H1	200.87	15.45
Smooth Muscle Cells - Bladder, donor1	11519-119H7	44.03	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	316.72	10.38
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	222.32	18.84
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	457.07	7.68
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	207.08	14.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	258.41	19.20
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	217.96	13.10
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	68.32	3.42
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	126.95	7.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	170.99	5.30
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	170.71	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	222.98	17.84
Smooth Muscle Cells - Colonic, donor2	11320-117D6	153.03	15.07
Smooth Muscle Cells - Colonic, donor3	11396-118D1	173.71	16.37
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	206.96	8.97
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	136.89	7.55
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	229.22	10.16
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	53.26	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	129.89	4.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	170.79	20.63
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	291.95	10.01
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	179.94	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	210.62	9.80
Smooth Muscle Cells - Prostate, donor1	11257-116F6	163.12	20.77
Smooth Muscle Cells - Prostate, donor2	11335-117F3	145.76	13.65
Smooth Muscle Cells - Prostate, donor3	11465-119B7	165.90	7.61
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	323.71	11.76
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	176.29	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	126.64	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	226.49	7.44
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	207.51	5.55
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	184.28	9.72
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	62.24	4.42
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	257.67	8.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	144.82	7.94
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	320.79	14.54
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	268.72	7.14
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	158.89	9.59
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	246.51	14.25
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	264.10	15.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	2.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	294.33	13.70
Smooth Muscle Cells - Uterine, donor1	11258-116F7	274.86	11.71
Smooth Muscle Cells - Uterine, donor3	11466-119B8	146.00	11.70
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	54.62	10.30
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	128.52	13.49
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	104.52	9.30
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	104.21	11.14
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	139.11	9.65
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	214.66	14.97
Smooth muscle cells - airway, control, donor1	11966-126D4	102.60	11.17
Smooth muscle cells - airway, control, donor2	11967-126D5	67.48	11.98
Smooth muscle cells - airway, control, donor3	11968-126D6	87.78	9.61
Smooth muscle cells - airway, control, donor4	11969-126D7	72.42	8.25
Synoviocyte, donor1	11291-117A4	345.23	17.34
Synoviocyte, donor2	11368-117I9	128.90	13.41
Synoviocyte, donor3	11440-118H9	99.86	7.37
Trabecular Meshwork Cells, donor1	11532-120A2	81.47	5.36
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	38.67	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	107.96	10.11
Tracheal Epithelial Cells, donor2	11369-118A1	76.93	4.25
Tracheal Epithelial Cells, donor3	11441-118I1	48.10	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	146.52	23.62
Urethra, donor2	10319-105A4	147.47	10.79
Urothelial Cells, donor1	11520-119H8	65.09	5.05
Urothelial Cells, donor2	11600-120H7	42.86	2.40
Urothelial Cells, donor3	11681-122H7	42.63	2.06
Urothelial cells, donor0	11216-116B1	145.33	8.47
Whole blood (ribopure), donor090309, donation1	12179-129A1	1006.34	38.26
Whole blood (ribopure), donor090309, donation2	12180-129A2	1052.19	45.75
Whole blood (ribopure), donor090309, donation3	12181-129A3	436.04	16.43
Whole blood (ribopure), donor090325, donation1	12176-128I7	673.87	16.18
Whole blood (ribopure), donor090325, donation2	12177-128I8	729.19	15.11
Whole blood (ribopure), donor090612, donation1	12182-129A4	963.15	32.28
Whole blood (ribopure), donor090612, donation2	12183-129A5	891.18	42.22
Whole blood (ribopure), donor090612, donation3	12184-129A6	463.75	10.04
Wilms' tumor cell line:G-401	10809-111A8	91.78	7.03
Wilms' tumor cell line:HFWT	10597-108E3	191.85	19.36
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	92.73	34.64
achilles tendon, donor2	10292-104G4	144.66	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	281.22	7.90
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	180.86	11.38
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	194.32	19.82
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	447.90	16.05
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	257.75	5.90
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	438.61	12.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	164.42	5.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	139.24	10.58
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	154.36	5.72
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	172.02	10.10
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	127.51	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	276.94	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	164.29	14.41
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	230.42	11.13
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	251.62	6.72
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	166.85	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	522.70	15.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	230.52	11.05
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	537.23	15.79
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	637.22	17.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	556.75	18.53
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	251.03	16.93
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	122.75	20.35
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	70.61	16.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	133.71	7.91
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	140.00	13.52
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	193.07	18.74
adenocarcinoma cell line:IM95m	10796-110I4	56.28	17.43
adipose tissue, adult, pool1	10010-101C1	173.58	11.17
adipose, donor1	10184-103D4	135.46	63.92
adipose, donor2	10185-103D5	19.06	13.79
adipose, donor3	10186-103D6	48.20	14.43
adipose, donor4	10187-103D7	45.07	27.74
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	61.71	24.94
adrenal gland, adult, pool1	10081-102A9	25.46	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	139.01	23.48
alveolar cell carcinoma cell line:SW 1573	10708-109H6	86.47	5.36
amniotic membrane cells, donor1	12235-129G3	97.14	22.49
amniotic membrane cells, donor2	12236-129G4	104.81	20.29
amniotic membrane cells, donor3	12237-129G5	66.87	17.09
amygdala - adult, donor10196	10167-103B5	62.85	22.53
amygdala, adult, donor10252	10151-102I7	96.11	27.37
amygdala, newborn, donor10223	10360-105E9	83.27	8.07
anaplastic carcinoma cell line:8305C	10428-106D5	80.98	12.22
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	204.96	15.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	45.10	10.02
aorta, adult, pool1	10052-101G7	83.16	9.41
appendix, adult	10189-103D9	215.02	27.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	149.96	33.02
artery, adult	10190-103E1	33.97	10.87
astrocytoma cell line:TM-31	10425-106D2	165.73	43.32
b cell line:RPMI1788	10427-106D4	258.74	18.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	451.96	21.64
bile duct carcinoma cell line:HuCCT1	10432-106D9	114.71	6.65
bile duct carcinoma cell line:TFK-1	10496-107C1	61.26	16.91
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	159.94	4.47
bladder, adult, pool1	10011-101C2	102.23	16.40
blood, adult, pool1	10053-101G8	312.26	8.86
bone marrow stromal cell line:StromaNKtert	10686-109F2	270.61	25.69
bone marrow, adult	10192-103E3	164.66	10.80
brain, adult, donor1	10084-102B3	34.85	9.23
brain, adult, pool1	10012-101C3	63.14	19.71
brain, fetal, pool1	10085-102B4	101.51	24.04
breast carcinoma cell line:MCF7	10482-107A5	98.12	16.52
breast carcinoma cell line:MDA-MB-453	10419-106C5	80.89	29.71
breast, adult, donor1	10080-102A8	67.56	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	74.32	7.88
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	104.83	16.70
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	92.09	8.98
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	127.82	10.41
carcinoid cell line:NCI-H1770	10703-109H1	78.99	55.01
carcinoid cell line:NCI-H727	10735-110B6	71.75	7.00
carcinoid cell line:SK-PN-DW	10719-109I8	121.05	25.03
carcinosarcoma cell line:JHUCS-1	10642-109A3	119.78	33.27
caudate nucleus - adult, donor10196	10177-103C6	64.47	10.36
caudate nucleus, adult, donor10252	10164-103B2	92.53	24.43
caudate nucleus, adult, donor10258	10379-105H1	52.73	9.93
caudate nucleus, newborn, donor10223	10354-105E3	83.13	5.49
cerebellum - adult, donor10196	10173-103C2	43.70	20.39
cerebellum, adult, donor10252	10166-103B4	41.85	30.53
cerebellum, adult, pool1	10083-102B2	20.70	15.87
cerebellum, newborn, donor10223	10357-105E6	67.25	9.96
cerebral meninges, adult	10188-103D8	83.71	19.67
cerebrospinal fluid, donor2	10294-104G6	78.94	8.04
cervical cancer cell line:D98-AH2	10552-107I3	115.17	15.10
cervical cancer cell line:ME-180	10553-107I4	112.19	11.43
cervix, adult, pool1	10013-101C4	119.69	16.48
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	172.22	28.29
chondrosarcoma cell line:SW 1353	10700-109G7	159.36	5.23
choriocarcinoma cell line:BeWo	10423-106C9	295.40	51.08
choriocarcinoma cell line:SCH	10785-110H2	93.64	39.06
choriocarcinoma cell line:T3M-3	10618-108G6	198.52	53.84
chorionic membrane cells, donor1	12238-129G6	146.16	15.96
chorionic membrane cells, donor2	12239-129G7	301.77	20.38
chorionic membrane cells, donor3	12240-129G8	259.91	17.03
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	183.78	13.13
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	221.11	7.30
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	184.58	7.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	65.74	14.89
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.99	18.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	71.87	15.88
chronic myelogenous leukemia cell line:K562	10454-106G4	93.05	21.20
chronic myelogenous leukemia cell line:KU812	10409-106B4	149.86	11.73
clear cell carcinoma cell line:JHOC-5	10638-108I8	79.77	17.37
clear cell carcinoma cell line:TEN	10636-108I6	47.89	17.00
colon carcinoma cell line:CACO-2	10513-107D9	116.78	31.30
colon carcinoma cell line:COLO-320	10420-106C6	58.91	41.05
colon, adult, donor1	10082-102B1	70.21	8.33
colon, adult, pool1	10014-101C5	180.84	14.22
colon, fetal, donor1	10070-101I7	76.63	12.36
common myeloid progenitor CMP, donor1	12130-128D6	77.92	4.58
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	103.68	8.92
cord blood derived cell line:COBL-a 24h infection	10453-106G3	145.20	5.28
cord blood derived cell line:COBL-a untreated	10449-106F8	160.89	10.29
corpus callosum, adult, pool1	10042-101F6	120.51	29.30
cruciate ligament, donor2	10295-104G7	163.71	25.94
diaphragm, fetal, donor1	10069-101I6	55.38	8.83
diencephalon, adult	10193-103E4	65.76	27.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	167.39	13.55
ductal cell carcinoma cell line:KLM-1	10438-106E6	108.99	29.49
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.11	17.57
ductus deferens, adult	10196-103E7	67.77	17.94
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	15.84
duodenum, fetal, donor1, tech_rep2	10071-101I8	127.27	25.75
dura mater, adult, donor1	10041-101F5	241.32	11.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.31	4.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.24	10.75
embryonic pancreas cell line:1B2C6	10604-108F1	82.01	30.21
embryonic pancreas cell line:1C3D3	10605-108F2	84.76	19.98
embryonic pancreas cell line:1C3IKEI	10606-108F3	84.91	16.98
embryonic pancreas cell line:2C6	10603-108E9	110.33	22.33
endometrial carcinoma cell line:OMC-2	10497-107C2	64.69	36.87
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	274.57	21.39
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	105.49	25.89
epidermoid carcinoma cell line:A431	10426-106D3	99.71	23.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	141.11	13.53
epididymis, adult	10197-103E8	98.59	19.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	300.53	25.90
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	41.29	4.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	184.26	21.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	139.95	16.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	182.83	21.85
esophagus, adult, pool1	10015-101C6	149.39	13.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	63.75	10.14
eye - muscle inferior rectus, donor1	10272-104E2	115.90	14.49
eye - muscle lateral, donor2	10298-104H1	96.79	8.42
eye - muscle medial, donor2	10299-104H2	83.34	19.35
eye - muscle superior, donor2	10297-104G9	108.92	12.61
eye - vitreous humor, donor1	10268-104D7	61.21	14.57
eye, fetal, donor1	10054-101G9	51.36	12.97
fibrosarcoma cell line:HT-1080	10758-110E2	120.53	5.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	67.43	7.12
frontal lobe, adult, pool1	10040-101F4	80.59	26.46
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	189.76	34.53
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	157.73	11.34
gall bladder, adult	10198-103E9	89.57	14.49
gamma delta positive T cells, donor1	11937-126A2	253.40	26.31
gamma delta positive T cells, donor2	11938-126A3	341.00	9.71
gastric adenocarcinoma cell line:MKN1	10614-108G2	101.17	25.98
gastric adenocarcinoma cell line:MKN45	10612-108F9	46.42	18.95
gastric cancer cell line:AZ521	10549-107H9	85.26	13.77
gastric cancer cell line:GSS	10560-108A2	10.98	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.78	12.11
giant cell carcinoma cell line:LU65	10487-107B1	62.99	8.15
giant cell carcinoma cell line:Lu99B	10433-106E1	80.90	17.49
glassy cell carcinoma cell line:HOKUG	10688-109F4	114.73	6.73
glioblastoma cell line:A172, tech_rep1	10444-106F3	130.67	21.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	137.07	23.59
glioblastoma cell line:T98G	10485-107A8	134.10	11.04
glioma cell line:GI-1	10413-106B8	90.21	19.62
globus pallidus - adult, donor10196	10175-103C4	72.16	21.14
globus pallidus, adult, donor10252	10161-103A8	133.28	31.49
globus pallidus, adult, donor10258	10367-105F7	112.28	16.43
globus pallidus, newborn, donor10223	10364-105F4	69.28	5.33
granulocyte macrophage progenitor, donor1	12131-128D7	181.09	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	305.99	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	245.65	26.13
granulosa cell tumor cell line:KGN	10624-108H3	189.12	9.92
hIPS +CCl2, biol_rep1	14383-156B9	32.60	5.51
hIPS +CCl2, biol_rep2	14384-156C1	32.47	3.20
hIPS +CCl2, biol_rep3	14385-156C2	28.34	1.93
hIPS, biol_rep1	14380-156B6	24.43	4.31
hIPS, biol_rep2	14381-156B7	20.58	0.00
hIPS, biol_rep3	14382-156B8	51.86	14.35
hairy cell leukemia cell line:Mo	10712-109I1	158.33	12.64
heart - mitral valve, adult	10205-103F7	96.27	12.56
heart - pulmonic valve, adult	10206-103F8	59.35	14.12
heart - tricuspid valve, adult	10207-103F9	127.39	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	66.73	12.04
heart, adult, diseased, donor1	10051-101G6	37.90	8.09
heart, adult, pool1	10016-101C7	148.80	5.52
heart, fetal, pool1	10046-101G1	84.51	13.14
hepatic mesenchymal tumor cell line:LI90	10778-110G4	313.46	4.94
hepatoblastoma cell line:HuH-6	10633-108I3	70.16	14.27
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	82.43	13.92
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	90.18	12.74
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	87.01	12.63
hepatoma cell line:Li-7	10484-107A7	50.83	14.46
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	283.11	24.92
hippocampus - adult, donor10196	10169-103B7	88.01	15.14
hippocampus, adult, donor10252	10153-102I9	81.23	19.59
hippocampus, adult, donor10258	10374-105G5	38.84	10.95
hippocampus, newborn, donor10223	10363-105F3	74.37	5.99
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	51.88	13.43
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.94	4.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.55	5.59
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	26.50	10.15
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	27.11	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	27.33	12.53
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	41.75	16.64
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	42.87	11.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.20	12.51
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	89.98	20.36
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	66.70	12.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	98.30	15.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.68	6.26
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.32	10.32
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	15.71
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.13	20.43
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	33.58	18.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.47	26.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.52	10.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.10	10.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.70	15.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.67	18.62
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	52.26	15.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	53.51	21.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.03	7.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.82	7.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.87	14.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.29	13.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	40.86	12.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	51.75	15.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.64	11.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	42.51	13.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	52.85	14.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	83.85	13.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	81.02	15.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	86.03	13.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.36	4.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.53	8.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.88	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	38.20	11.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	335.08	94.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	51.30	16.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	14.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.57	7.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.03	9.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	58.48	10.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	86.40	17.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	63.31	11.58
immature langerhans cells, donor1	11904-125F5	443.37	5.81
immature langerhans cells, donor2	11905-125F6	215.46	10.30
insula, adult, pool1	10039-101F3	94.25	17.89
keratoacanthoma cell line:HKA-1	10791-110H8	107.95	11.06
kidney, adult, pool1	10017-101C8	112.54	14.42
kidney, fetal, pool1	10045-101F9	78.59	17.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	95.30	4.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	60.00	15.76
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	48.63	21.47
left atrium, adult, donor1	10079-102A7	66.47	4.36
left ventricle, adult, donor1	10078-102A6	53.09	1.52
leiomyoblastoma cell line:G-402	10721-110A1	82.90	15.60
leiomyoma cell line:10964C	10569-108B2	133.28	7.90
leiomyoma cell line:15242A	10570-108B3	172.28	3.80
leiomyoma cell line:15425	10571-108B4	162.44	18.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	393.66	44.45
lens epithelial cell line:SRA 01/04	10647-109A8	84.69	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	72.96	6.02
liposarcoma cell line:KMLS-1	10782-110G8	125.44	8.90
liposarcoma cell line:SW 872	10726-110A6	91.87	10.97
liver, adult, pool1	10018-101C9	79.90	18.64
liver, fetal, pool1	10086-102B5	34.81	8.47
locus coeruleus - adult, donor10196	10182-103D2	67.81	12.10
locus coeruleus, adult, donor10252	10165-103B3	84.52	21.41
locus coeruleus, adult, donor10258	10375-105G6	43.73	7.62
locus coeruleus, newborn, donor10223	10362-105F2	108.94	5.89
lung adenocarcinoma cell line:A549	10499-107C4	108.22	12.87
lung adenocarcinoma cell line:PC-14	10408-106B3	133.74	6.89
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	120.48	5.67
lung, adult, pool1	10019-101D1	253.03	18.07
lung, fetal, donor1	10068-101I5	248.59	44.52
lung, right lower lobe, adult, donor1	10075-102A3	145.25	11.00
lymph node, adult, donor1	10077-102A5	139.64	6.63
lymphangiectasia cell line:DS-1	10727-110A7	140.05	13.81
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	333.70	15.70
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	103.64	17.84
mature adipocyte, donor1	12231-129F8	62.60	10.21
mature adipocyte, donor2	12232-129F9	73.88	12.66
mature adipocyte, donor3	12233-129G1	51.21	6.64
mature adipocyte, donor4	12234-129G2	55.54	13.42
maxillary sinus tumor cell line:HSQ-89	10414-106B9	53.61	15.96
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	12.41
medial frontal gyrus, adult, donor10252	10150-102I6	69.88	21.33
medial frontal gyrus, adult, donor10258	10368-105F8	40.03	13.98
medial frontal gyrus, newborn, donor10223	10352-105E1	266.56	24.31
medial temporal gyrus - adult, donor10196	10183-103D3	68.34	11.64
medial temporal gyrus, adult, donor10252	10156-103A3	78.52	23.34
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	44.30	23.12
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	86.12
medial temporal gyrus, newborn, donor10223	10353-105E2	101.94	7.90
medulla oblongata - adult, donor10196	10174-103C3	58.41	12.98
medulla oblongata, adult, donor10252	10155-103A2	82.36	20.12
medulla oblongata, adult, pool1	10038-101F2	82.93	19.26
medulla oblongata, newborn, donor10223	10361-105F1	65.27	5.90
medulloblastoma cell line:D283 Med	10838-111E1	23.47	23.47
medulloblastoma cell line:ONS-76	10759-110E3	97.21	17.73
melanoma cell line:COLO 679	10514-107E1	84.24	7.19
melanoma cell line:G-361	10465-106H6	53.21	6.79
meningioma cell line:HKBMM	10691-109F7	114.51	7.60
merkel cell carcinoma cell line:MKL-1	10843-111E6	126.01	29.08
merkel cell carcinoma cell line:MS-1	10844-111E7	99.28	19.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	226.32	16.42
mesenchymal precursor cell - adipose, donor2	11748-123G2	145.79	6.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	172.68	7.45
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	212.12	6.04
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	179.47	13.86
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	145.06	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	246.98	13.73
mesenchymal precursor cell - cardiac, donor2	11753-123G7	196.22	6.79
mesenchymal precursor cell - cardiac, donor3	11754-123G8	249.23	12.20
mesenchymal precursor cell - cardiac, donor4	11755-123G9	330.04	9.86
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	313.26	13.66
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	136.35	9.55
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	284.35	22.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	212.94	17.80
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	289.10	10.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	140.91	14.74
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	226.55	20.17
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	156.40	17.56
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	533.26	26.43
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	257.03	22.12
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	231.78	18.73
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	205.80	16.94
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	163.11	16.02
mesenchymal stem cell line:Hu5/E18	10568-108B1	191.14	25.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	192.71	14.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	180.07	13.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	208.36	16.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	178.38	12.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	190.64	13.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	186.15	15.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	156.40	14.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	166.82	13.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	289.82	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	205.64	12.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	190.97	15.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	186.03	15.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	222.93	22.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	166.82	15.10
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	186.27	15.56
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	172.68	15.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	180.47	16.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	185.94	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	178.96	13.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	146.95	20.37
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	170.05	9.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	151.29	9.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	162.10	11.66
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	132.22	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	137.10	7.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	114.41	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	169.59	14.82
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	116.97	17.06
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	136.18	16.47
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	94.16	6.55
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	88.12	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	45.23	5.30
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	54.02	5.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.73	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.52	7.48
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	52.04	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	12.84
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	71.59	5.51
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	26.22	9.40
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	8.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	10.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.84	7.66
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	17.44
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	31.68	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	38.23	6.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	24.71	10.71
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	82.15	8.93
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	53.22	11.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	59.08	17.32
mesodermal tumor cell line:HIRS-BM	10696-109G3	285.50	40.23
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.03	46.78
mesothelioma cell line:ACC-MESO-4	10494-107B8	216.61	24.33
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	205.13	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	318.73	15.41
mesothelioma cell line:Mero-25	10850-111F4	170.44	15.66
mesothelioma cell line:Mero-41	10851-111F5	367.94	8.80
mesothelioma cell line:Mero-48a	10852-111F6	179.36	19.93
mesothelioma cell line:Mero-82	10853-111F7	124.57	5.78
mesothelioma cell line:Mero-83	10854-111F8	192.01	23.66
mesothelioma cell line:Mero-84	10855-111F9	203.48	14.16
mesothelioma cell line:Mero-95	10856-111G1	283.23	16.15
mesothelioma cell line:NCI-H2052	10847-111F1	52.68	0.66
mesothelioma cell line:NCI-H226	10846-111E9	148.59	5.61
mesothelioma cell line:NCI-H2452	10848-111F2	144.52	9.40
mesothelioma cell line:NCI-H28	10845-111E8	139.45	7.63
mesothelioma cell line:No36	10857-111G2	232.91	44.36
mesothelioma cell line:ONE58	10858-111G3	170.43	6.23
migratory langerhans cells, donor1	11901-125F2	996.27	26.10
migratory langerhans cells, donor2	11902-125F3	545.25	30.41
migratory langerhans cells, donor3	11903-125F4	798.69	11.31
mixed mullerian tumor cell line:HTMMT	10689-109F5	98.27	27.10
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	79.05	13.14
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	134.53	17.51
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	194.48	3.81
myelodysplastic syndrome cell line:SKM-1	10772-110F7	311.37	29.94
myeloma cell line:PCM6	10474-106I6	221.58	19.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	169.43	45.66
myxofibrosarcoma cell line:NMFH-1	10684-109E9	154.95	13.93
nasal epithelial cells, donor1, tech_rep1	12226-129F3	99.50	16.71
nasal epithelial cells, donor1, tech_rep2	12226-129F3	112.30	18.83
nasal epithelial cells, donor2	12227-129F4	97.70	13.25
neuroblastoma cell line:CHP-134	10508-107D4	38.65	22.78
neuroblastoma cell line:NB-1	10539-107G8	272.96	64.73
neuroblastoma cell line:NBsusSR	10607-108F4	66.43	18.98
neuroblastoma cell line:NH-12	10555-107I6	45.84	14.16
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	305.78	17.32
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	165.67	26.61
neuroectodermal tumor cell line:TASK1	10774-110F9	68.83	21.13
neuroepithelioma cell line:SK-N-MC	10728-110A8	84.56	37.51
neurofibroma cell line:Hs 53.T	10729-110A9	209.47	16.50
neutrophil PMN, donor1	12133-128D9	728.87	59.50
neutrophil PMN, donor2	12137-128E4	1540.56	53.12
neutrophil PMN, donor3	12141-128E8	1572.13	56.82
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	126.50	7.61
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	255.36	56.84
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	131.77	13.47
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	204.96	12.88
nucleus accumbens, adult, pool1	10037-101F1	82.21	19.12
occipital cortex - adult, donor10196	10172-103C1	70.05	12.36
occipital cortex, adult, donor10252	10163-103B1	89.90	23.88
occipital cortex, newborn, donor10223	10355-105E4	103.00	6.19
occipital lobe, adult, donor1	10076-102A4	54.05	14.17
occipital lobe, fetal, donor1	10073-102A1	112.85	35.62
occipital pole, adult, pool1	10036-101E9	43.52	16.64
olfactory region, adult	10195-103E6	54.26	19.68
optic nerve, donor1	10277-104E7	142.07	60.03
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	107.42	23.12
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	51.25	21.29
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	155.27	27.26
oral squamous cell carcinoma cell line:SAS	10544-107H4	63.30	3.47
osteoclastoma cell line:Hs 706.T	10704-109H2	244.29	17.64
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	122.40	7.47
osteosarcoma cell line:HS-Os-1	10558-107I9	138.47	30.11
ovary, adult, pool1	10020-101D2	99.41	11.36
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	93.13	8.98
pancreas, adult, donor1	10049-101G4	54.56	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	143.40	20.69
papillary adenocarcinoma cell line:8505C	10437-106E5	125.21	12.10
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	157.63	16.06
paracentral gyrus, adult, pool1	10035-101E8	70.01	17.39
parietal cortex, adult, donor10258	10373-105G4	46.98	11.01
parietal lobe - adult, donor10196	10171-103B9	58.31	15.99
parietal lobe, adult, donor10252	10157-103A4	65.84	21.95
parietal lobe, adult, pool1	10034-101E7	72.96	20.62
parietal lobe, fetal, donor1	10072-101I9	134.81	31.03
parietal lobe, newborn, donor10223	10356-105E5	108.42	12.34
parotid gland, adult	10199-103F1	54.27	9.87
penis, adult	10200-103F2	67.14	24.71
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	33.65	7.44
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	100.38	15.15
pineal gland - adult, donor10196	10179-103C8	50.96	12.26
pineal gland, adult, donor10252	10160-103A7	96.53	26.65
pineal gland, adult, donor10258	10377-105G8	37.62	11.91
pituitary gland - adult, donor10196	10180-103C9	80.94	17.20
pituitary gland, adult, donor10252	10162-103A9	99.55	40.65
pituitary gland, adult, donor10258	10378-105G9	34.05	20.43
placenta, adult, pool1	10021-101D3	310.04	26.45
plasma cell leukemia cell line:ARH-77	10840-111E3	169.51	21.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	184.12	28.79
pons, adult, pool1	10033-101E6	67.99	16.27
postcentral gyrus, adult, pool1	10032-101E5	60.33	18.48
promyelocytes/myelocytes PMC, donor1	12132-128D8	146.40	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	297.43	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	305.13	0.00
prostate cancer cell line:DU145	10490-107B4	128.18	21.27
prostate cancer cell line:PC-3	10439-106E7	88.21	16.52
prostate, adult, pool1	10022-101D4	85.52	11.43
putamen, adult, donor10196	10176-103C5	107.88	17.00
putamen, adult, donor10252	10152-102I8	119.60	17.65
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	54.12	13.53
putamen, newborn, donor10223	10365-105F5	162.68	5.25
rectal cancer cell line:TT1TKB	10469-106I1	58.77	10.47
rectum, fetal, donor1	10067-101I4	87.63	19.47
renal cell carcinoma cell line:OS-RC-2	10411-106B6	152.85	13.78
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	2.90
retina, adult, pool1	10030-101E3	69.28	18.99
retinoblastoma cell line:Y79	10475-106I7	62.09	12.73
rhabdomyosarcoma cell line:KYM-1	10787-110H4	80.78	27.17
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	53.71	16.31
sacrococcigeal teratoma cell line:HTST	10695-109G2	120.50	24.25
salivary acinar cells, donor1	11771-123I7	71.06	13.43
salivary acinar cells, donor2	11772-123I8	69.12	14.04
salivary acinar cells, donor3	11773-123I9	94.67	15.23
salivary gland, adult, pool1	10093-102C3	84.65	14.30
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	158.67	10.20
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	165.98	10.11
seminal vesicle, adult	10201-103F3	67.19	6.88
serous adenocarcinoma cell line:JHOS-2	10639-108I9	163.97	21.38
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	103.92	8.81
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	145.51	11.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	35.86	8.73
signet ring carcinoma cell line:Kato III	10436-106E4	92.40	11.27
signet ring carcinoma cell line:NUGC-4	10483-107A6	103.22	7.48
skeletal muscle - soleus muscle, donor1	10282-104F3	29.79	7.09
skeletal muscle, adult, pool1	10023-101D5	65.49	4.80
skeletal muscle, fetal, donor1	10066-101I3	18.09	1.01
skin, adult, donor1	10074-102A2	101.78	20.36
skin, fetal, donor1	10065-101I2	130.03	11.99
small cell cervical cancer cell line:HCSC-1	10800-110I8	105.39	25.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	132.39	32.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	46.45	37.20
small cell lung carcinoma cell line:LK-2	10541-107H1	66.43	12.20
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.50	10.94
small cell lung carcinoma cell line:WA-hT	10562-108A4	109.83	18.96
small intestine, adult, pool1	10024-101D6	219.66	31.06
small intestine, fetal, donor1	10064-101I1	100.24	19.66
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	105.66	11.80
smooth muscle, adult, pool1	10048-101G3	61.51	11.37
somatostatinoma cell line:QGP-1	10781-110G7	73.44	8.58
spinal cord - adult, donor10196	10181-103D1	88.32	13.99
spinal cord, adult, donor10252	10159-103A6	117.10	24.44
spinal cord, adult, donor10258	10369-105F9	96.16	15.91
spinal cord, fetal, donor1	10056-101H2	96.35	22.56
spinal cord, newborn, donor10223	10359-105E8	170.37	13.78
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	367.26	15.08
spleen, adult, pool1	10025-101D7	322.80	12.22
spleen, fetal, pool1	10044-101F8	215.96	10.89
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	296.46	25.26
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	93.42	20.89
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	127.55	31.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	52.38	6.25
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	42.32	11.93
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	87.69	44.90
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	99.84	17.77
stomach, fetal, donor1	10062-101H8	138.84	27.77
submaxillary gland, adult	10202-103F4	66.08	11.96
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	112.58	30.95
substantia nigra, adult, donor10258	10371-105G2	35.17	9.31
substantia nigra, newborn, donor10223	10358-105E7	113.76	9.89
synovial sarcoma cell line:HS-SY-II	10441-106E9	155.90	28.66
temporal lobe, adult, pool1	10031-101E4	62.65	17.80
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	155.27	29.92
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	127.91	33.84
tenocyte, donor1	11763-123H8	223.42	8.73
tenocyte, donor2	11765-123I1	155.27	8.77
tenocyte, donor3	11768-123I4	198.31	11.12
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	103.85	16.66
teratocarcinoma cell line:NCR-G1	10798-110I6	56.57	16.34
teratocarcinoma cell line:PA-1	10807-111A6	51.30	6.35
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	126.69	12.06
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.55	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	91.50	16.36
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	39.41	8.79
testis, adult, pool1	10026-101D8	115.21	32.00
testis, adult, pool2	10096-102C6	70.82	38.34
thalamus - adult, donor10196	10168-103B6	79.49	22.08
thalamus, adult, donor10252	10154-103A1	94.86	30.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	18.48
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.10	8.23
thalamus, newborn, donor10223	10366-105F6	93.78	5.75
throat, adult	10209-103G2	83.14	13.23
throat, fetal, donor1	10061-101H7	86.84	12.49
thymic carcinoma cell line:Ty-82	10803-111A2	19.87	10.14
thymus, adult, pool1	10027-101D9	271.20	13.82
thymus, fetal, pool1	10043-101F7	249.68	14.96
thyroid carcinoma cell line:KHM-5M	10776-110G2	182.95	12.10
thyroid carcinoma cell line:TCO-1	10783-110G9	122.51	24.31
thyroid, adult, pool1	10028-101E1	107.68	23.33
thyroid, fetal, donor1	10060-101H6	72.24	14.24
tongue epidermis (fungiform papillae), donor1	10288-104F9	101.63	9.24
tongue, adult	10203-103F5	72.33	12.79
tongue, fetal, donor1	10059-101H5	75.27	6.31
tonsil, adult, pool1	10047-101G2	227.60	15.63
trachea, adult, pool1	10029-101E2	146.91	7.61
trachea, fetal, donor1	10058-101H4	75.02	10.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	239.14	6.38
transitional-cell carcinoma cell line:5637	10418-106C4	141.13	10.03
transitional-cell carcinoma cell line:JMSU1	10492-107B6	52.65	14.42
tridermal teratoma cell line:HGRT	10694-109G1	121.76	26.64
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	69.50	16.34
umbilical cord, fetal, donor1	10057-101H3	127.28	16.69
uterus, adult, pool1	10100-102D1	150.32	24.57
uterus, fetal, donor1	10055-101H1	124.40	26.11
vagina, adult	10204-103F6	80.13	10.99
vein, adult	10191-103E2	143.79	10.30
xeroderma pigentosum b cell line:XPL 17	10563-108A5	174.38	16.56